Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Aeromedical aspects of findings from aircraft-assisted pilot suicides in the United States, 1993-2002 [[electronic resource] ] : final report / / Robert D. Johnson ... [and others]
| Aeromedical aspects of findings from aircraft-assisted pilot suicides in the United States, 1993-2002 [[electronic resource] ] : final report / / Robert D. Johnson ... [and others] |
| Pubbl/distr/stampa | Washington, DC : , : Federal Aviation Administration, Office of Aerospace Medicine, , [2006] |
| Descrizione fisica | i, 11 pages : digital, PDF file |
| Altri autori (Persone) | JohnsonRobert D <1974-> (Robert David) |
| Soggetto topico |
Air pilots - Suicidal behavior - United States
Aircraft accidents - Human factors - United States Accidents, Aviation Aerospace Medicine - methods Aviation Substance-Related Disorders Suicide |
| Soggetto genere / forma |
Case Reports.
Technical Report |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Aeromedical aspects of findings from aircraft-assisted pilot suicides in the United States, 1993-2002 |
| Record Nr. | UNINA-9910695371003321 |
| Washington, DC : , : Federal Aviation Administration, Office of Aerospace Medicine, , [2006] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance
| Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
| Autore | Organization World Health |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
| Soggetto genere / forma |
Electronic books.
Publication Formats Technical Report |
| ISBN | 92-4-069266-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
| Record Nr. | UNINA-9910511992203321 |
Organization World Health
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance
| Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
| Autore | Organization World Health |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
| Soggetto genere / forma |
Publication Formats
Technical Report |
| ISBN | 92-4-069266-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
| Record Nr. | UNINA-9910786624203321 |
|
Organization World Health
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance
| Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
| Autore | Organization World Health |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
| Soggetto genere / forma |
Publication Formats
Technical Report |
| ISBN | 92-4-069266-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
| Record Nr. | UNINA-9910825162403321 |
|
Organization World Health
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Enantiomeric analysis of ephedrines and norephedrines [[electronic resource] ] : final report / / S.M. Wang ... [and others]
| Enantiomeric analysis of ephedrines and norephedrines [[electronic resource] ] : final report / / S.M. Wang ... [and others] |
| Pubbl/distr/stampa | Washington, DC : , : U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aerospace Medicine |
| Descrizione fisica | iii, 10 pages : digital, PDF file |
| Altri autori (Persone) | WangS. M |
| Soggetto topico |
Ephedrine - Analysis
Phenylpropanolamine - Analysis Ephedrine - analysis Norepinephrine - analysis Designer Drugs - analysis |
| Soggetto genere / forma | Technical Report |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Enantiomeric analysis of ephedrines and norephedrines |
| Record Nr. | UNINA-9910695363803321 |
| Washington, DC : , : U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aerospace Medicine | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evaluation of the Arkansas Tobacco Settlement Program : Progress Through 2011 – Summary
| Evaluation of the Arkansas Tobacco Settlement Program : Progress Through 2011 – Summary |
| Pubbl/distr/stampa | [Place of publication not identified], : RAND Corporation The, 2012 |
| Disciplina | 338.4/7616865061 |
| Collana | Technical report / Rand Corporation Evaluation of the Arkansas tobacco settlement program |
| Soggetto topico |
Smoking cessation - Government policy - Evaluation - Arkansas
Tobacco industry - Health aspects - Arkansas Tobacco industry - Law and legislation - Arkansas Health promotion - Arkansas Remedies (Law) Tobacco Use Cessation - methods Health Promotion Outcome Assessment, Health Care Program Evaluation Tobacco Industry - legislation & jurisprudence Tobacco Industry - economics |
| Soggetto genere / forma | Technical Report |
| ISBN | 0-8330-7946-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910220150103321 |
| [Place of publication not identified], : RAND Corporation The, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Gas chromatographic/mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol [[electronic resource] ] : final report / / Mike K. Angier ... [and others]
| Gas chromatographic/mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol [[electronic resource] ] : final report / / Mike K. Angier ... [and others] |
| Pubbl/distr/stampa | Washington, DC : , : Office of Aerospace Medicine, U.S. Dept. of Transportation, Federal Aviation Administration |
| Descrizione fisica | i, 6 pages : digital, PDF file |
| Altri autori (Persone) | AngierMike K |
| Soggetto topico |
Air pilots - Mortality - United States
Aircraft accidents - Mortality - United States Air pilots - Drug use - United States Forensic toxicology - United States Adrenergic beta blockers - Analysis Adrenergic beta-Antagonists - isolation & purification Atenolol - isolation & purification Gas Chromatography-Mass Spectrometry Metoprolol - isolation & purification Propranolol - isolation & purification Sensitivity and Specificity |
| Soggetto genere / forma | Technical Report |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Gas chromatographic/mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol |
| Record Nr. | UNINA-9910697484103321 |
| Washington, DC : , : Office of Aerospace Medicine, U.S. Dept. of Transportation, Federal Aviation Administration | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A historical review of color vision standards for air traffic control specialists at automated flight service stations [[electronic resource] ] : final report / / Nelda J. Milburn
| A historical review of color vision standards for air traffic control specialists at automated flight service stations [[electronic resource] ] : final report / / Nelda J. Milburn |
| Autore | Milburn Nelda J |
| Pubbl/distr/stampa | Washington, D.C. : , : U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aviation Medicine |
| Descrizione fisica | i, 8 pages : digital, PDF file |
| Soggetto topico |
Color vision - Testing
Air traffic controllers - Medical examinations - United States Color Vision Defects - diagnosis Aviation - history History, 20th Century Vision Screening - history |
| Soggetto genere / forma | Technical Report |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Historical review of color vision standards for air traffic control specialists at automated flight service stations |
| Record Nr. | UNINA-9910697590603321 |
|
Milburn Nelda J
|
||
| Washington, D.C. : , : U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aviation Medicine | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Identification of Sildenafil (Viagra) and its metabolite (UK-103,320) in six aviation fatalities [[electronic resource] ] : final report / / Robert D. Johnson, Russell J. Lewis
| Identification of Sildenafil (Viagra) and its metabolite (UK-103,320) in six aviation fatalities [[electronic resource] ] : final report / / Robert D. Johnson, Russell J. Lewis |
| Autore | Johnson Robert D (Robert David), <1974-> |
| Pubbl/distr/stampa | Washington, D.C. : , : Federal Aviation Administration, Office of Aerospace Medicine |
| Descrizione fisica | i, 11 pages : digital, PDF file |
| Altri autori (Persone) | LewisRussell J |
| Soggetto topico |
Aircraft accidents - Human factors
Sildenafil Piperazines - analysis Vasodilator Agents - analysis Accidents, Aviation Chromatography, High Pressure Liquid - methods Mass Spectrometry - methods |
| Soggetto genere / forma | Technical Report |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Identification of Sildenafil |
| Record Nr. | UNINA-9910695371703321 |
|
Johnson Robert D (Robert David), <1974->
|
||
| Washington, D.C. : , : Federal Aviation Administration, Office of Aerospace Medicine | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Interpretation of carboxyhemoglobin and cyanide concentrations in relation to aviation accidents [[electronic resource] ] : final report / / Dennis V. Canfield, Arvind K. Chaturvedi, Kurt M. Dubowski
| Interpretation of carboxyhemoglobin and cyanide concentrations in relation to aviation accidents [[electronic resource] ] : final report / / Dennis V. Canfield, Arvind K. Chaturvedi, Kurt M. Dubowski |
| Autore | Canfield Dennis V. <1943-> |
| Pubbl/distr/stampa | Washington, DC : , : U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aerospace Medicine |
| Descrizione fisica | i, 6 pages : digital, PDF file |
| Altri autori (Persone) |
ChaturvediArvind K
DubowskiKurt M |
| Soggetto topico |
Aircraft accidents
Carbon monoxide - Toxicology Carbon Monoxide Poisoning Accidents, Aviation Carbon Monoxide - blood Carboxyhemoglobin Cyanides - blood Fires |
| Soggetto genere / forma | Technical Report |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Interpretation of carboxyhemoglobin and cyanide concentrations in relation to aviation accidents |
| Record Nr. | UNINA-9910695363703321 |
|
Canfield Dennis V. <1943->
|
||
| Washington, DC : , : U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aerospace Medicine | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto genere / forma
-
Technical Report
(17)
- Publication Formats (3)
- Periodical (2)
- Case Reports. (1)
- Electronic books. (1)